Adds to existing law to establish provisions regarding breast cancer screening.

This legislation may lead to increased costs to the state due to increased screening outlay for individuals insured through the state health insurance plan. Such aggregate screening costs for the high-risk population at issue are estimated to be in the range of $36,000 to $72,000 total. However, there are likely to be significant offsetting savings from early detection of breast cancers that may actually lead to a net saving to the state from this bill. Late-stage cancer treatment is extremely costly; chemotherapy can range from $100,000 to $500,000 per patient, and radiation therapy can range from $50,000 to $100,000 per patient. Early cancer detection through more accurate screening technology will likely decrease the incidence of these much larger outlays.